Related Experiment Video
Updated: Mar 6, 2026

06:28
Screening Cotton Genotypes for Reniform Nematode Resistance
Published on: May 2, 2019
11.7K
Cancer Screening Test Use - United States, 2015
MMWR. Morbidity and Mortality Weekly Report
|March 3, 2017
Summary
Cancer screening rates for breast and cervical cancers remain below Healthy People 2020 targets. Colorectal cancer screening increased, but disparities persist, requiring targeted interventions to improve screening test use.
Area of Science:
- Public Health
- Preventive Medicine
- Cancer Control
Background:
- Healthy People 2020 (HP2020) set national objectives to enhance cancer screening rates.
- Screening recommendations are guided by the U.S. Preventive Services Task Force (USPSTF).
Purpose of the Study:
- To assess progress toward HP2020 cancer screening objectives using national survey data.
- To identify disparities in cancer screening test utilization.
Main Methods:
- Analysis of 2015 National Health Interview Survey (NHIS) data.
- Comparison of observed cancer screening test use against HP2020 national targets.
Main Results:
- Cancer screening test use remains significantly below HP2020 targets.
- Colorectal cancer screening use increased between 2000 and 2015.
- No improvements in breast and cervical cancer screening test use were observed.
- Significant disparities in screening exist based on race/ethnicity, socioeconomic status, and healthcare access.
Conclusions:
- Evidence-based interventions and targeted outreach are crucial to achieve HP2020 cancer screening goals.
- Addressing disparities is essential for equitable cancer screening test use.

